Skip to main content
Premium Trial:

Request an Annual Quote

Quanterix Licenses Traumatic Brain Injury Assays From Banyan Biomarkers

NEW YORK (GenomeWeb) – Quanterix announced it has licensed two assays from Banyan Biomarkers to bolster its research-use test menu for traumatic brain injury (TBI).

Under the terms of the agreement, Lexington, Massachusetts-based Quanterix will develop the Banyan UCH-L1 and GFAP assays for its Simoa single-molecule array technology. It will also incorporate the biomarkers into multiplex assays for research use in neurology.

Financial and other terms of the agreement were not disclosed.

"Simoa technology can detect biomarkers associated with brain injury and disease at much earlier stages to understand the long-term effects and disease pathology," the firm said in a statement. CEO Kevin Hrusovsky added that the firm will be "best positioned to develop the most accurate and predictive tests for concussions, [chronic traumatic encephalitis], TBI, and other neurological disorders."

Both Quanterix and Banyan received money from the GE and National Football League Head Health Challenge Grant program.

The deal helps Quanterix with its goal to double its test menu to 80 assays by the end of the year.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.